147 related articles for article (PubMed ID: 37679990)
41. Galantamine for Alzheimer's disease.
Loy C; Schneider L
Cochrane Database Syst Rev; 2004 Oct; (4):CD001747. PubMed ID: 15495017
[TBL] [Abstract][Full Text] [Related]
42. Randomized Phase II Study of the Safety and Efficacy of Semorinemab in Participants With Mild-to-Moderate Alzheimer Disease: Lauriet.
Monteiro C; Toth B; Brunstein F; Bobbala A; Datta S; Ceniceros R; Sanabria Bohorquez SM; Anania VG; Wildsmith KR; Schauer SP; Lee J; Dolton MJ; Ramakrishnan V; Abramzon D; Teng E;
Neurology; 2023 Oct; 101(14):e1391-e1401. PubMed ID: 37643887
[TBL] [Abstract][Full Text] [Related]
43. The efficacy and safety of the Chinese herbal medicine Di-Tan decoction for treating Alzheimer's disease: protocol for a randomized controlled trial.
Chua KK; Wong A; Kwan PW; Song JX; Chen LL; Chan AL; Lu JH; Mok V; Li M
Trials; 2015 Apr; 16():199. PubMed ID: 25925312
[TBL] [Abstract][Full Text] [Related]
44. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
45. Acupuncture for patients with mild to moderate Alzheimer's disease: a randomized controlled trial.
Jia Y; Zhang X; Yu J; Han J; Yu T; Shi J; Zhao L; Nie K
BMC Complement Altern Med; 2017 Dec; 17(1):556. PubMed ID: 29284465
[TBL] [Abstract][Full Text] [Related]
46. Efficacy of multivitamin supplementation containing vitamins B6 and B12 and folic acid as adjunctive treatment with a cholinesterase inhibitor in Alzheimer's disease: a 26-week, randomized, double-blind, placebo-controlled study in Taiwanese patients.
Sun Y; Lu CJ; Chien KL; Chen ST; Chen RC
Clin Ther; 2007 Oct; 29(10):2204-14. PubMed ID: 18042476
[TBL] [Abstract][Full Text] [Related]
47. Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer's disease: a 6-month, randomized, placebo-controlled, multicenter trial.
Wade AG; Farmer M; Harari G; Fund N; Laudon M; Nir T; Frydman-Marom A; Zisapel N
Clin Interv Aging; 2014; 9():947-61. PubMed ID: 24971004
[TBL] [Abstract][Full Text] [Related]
48. Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo-controlled trial.
Akhondzadeh S; Noroozian M; Mohammadi M; Ohadinia S; Jamshidi AH; Khani M
J Clin Pharm Ther; 2003 Feb; 28(1):53-9. PubMed ID: 12605619
[TBL] [Abstract][Full Text] [Related]
49. Reliability and concurrent validity of Alzheimer's disease assessment scale - Cognitive subscale, Chinese version (ADAS-Cog-C) among Chinese community-dwelling older people population.
Jiang Y; Yang H; Zhao J; Wu Y; Zhou X; Cheng Z
Clin Neuropsychol; 2020 Dec; 34(sup1):43-53. PubMed ID: 32279575
[TBL] [Abstract][Full Text] [Related]
50. Perspectives in the management of Alzheimer's disease: clinical profile of donepezil.
Rogers SL
Dement Geriatr Cogn Disord; 1998; 9 Suppl 3():29-42. PubMed ID: 9853200
[TBL] [Abstract][Full Text] [Related]
51. Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: a randomized, double-blind, placebo-controlled trial.
Porsteinsson AP; Grossberg GT; Mintzer J; Olin JT;
Curr Alzheimer Res; 2008 Feb; 5(1):83-9. PubMed ID: 18288936
[TBL] [Abstract][Full Text] [Related]
52. A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase IIb Clinical Study to Evaluate the Safety and Efficacy of DHP1401 in Patients with Mild to Moderate Alzheimer's Disease Treated with Donepezil: DHP1401 Randomized Trial in Mild to Moderate Alzheimer's Disease (DRAMA).
Shim Y; Han HJ; Park KW; Kim BC; Park KH; Park MY; Kim HJ; Moon SY; Choi SH; Park KW; Yang DW; Yoon SJ; Kim SY; Youn YC; Choi H; Yoon KE; Cho HJ; Han SH
J Alzheimers Dis; 2022; 87(1):391-403. PubMed ID: 35275529
[TBL] [Abstract][Full Text] [Related]
53. Selegiline for Alzheimer's disease.
Birks J; Flicker L
Cochrane Database Syst Rev; 2003; (1):CD000442. PubMed ID: 12535396
[TBL] [Abstract][Full Text] [Related]
54. Effects of Chinese medicine for tonifying the kidney and resolving phlegm and blood stasis in treating patients with amnestic mild cognitive impairment: a randomized, double-blind and parallel-controlled trial.
Miao YC; Tian JZ; Shi J; Mao M
Zhong Xi Yi Jie He Xue Bao; 2012 Apr; 10(4):390-7. PubMed ID: 22500712
[TBL] [Abstract][Full Text] [Related]
55. [Different care models and symptom progression of Alzheimer's disease in China].
Liao ZL; Chen Y; Tan YF; Zhu JP; Qiu YJ; Lin SS; Wu MH; Mao YP; Yu EY
Zhonghua Yi Xue Za Zhi; 2019 Feb; 99(7):532-536. PubMed ID: 30786352
[No Abstract] [Full Text] [Related]
56. Factors contributing to cognitive improvement effects of acupuncture in patients with mild cognitive impairment: a pilot randomized controlled trial.
Kim JH; Cho MR; Shin JC; Park GC; Lee JS
Trials; 2021 May; 22(1):341. PubMed ID: 33980288
[TBL] [Abstract][Full Text] [Related]
57. A multicenter, double-blind, placebo-controlled trial of the PDE9A inhibitor, PF-04447943, in Alzheimer's disease.
Schwam EM; Nicholas T; Chew R; Billing CB; Davidson W; Ambrose D; Altstiel LD
Curr Alzheimer Res; 2014; 11(5):413-21. PubMed ID: 24801218
[TBL] [Abstract][Full Text] [Related]
58. Vitamin E for Alzheimer's dementia and mild cognitive impairment.
Farina N; Llewellyn D; Isaac MGEKN; Tabet N
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD002854. PubMed ID: 28418065
[TBL] [Abstract][Full Text] [Related]
59. A long-term comparison of galantamine and donepezil in the treatment of Alzheimer's disease.
Wilcock G; Howe I; Coles H; Lilienfeld S; Truyen L; Zhu Y; Bullock R; Kershaw P;
Drugs Aging; 2003; 20(10):777-89. PubMed ID: 12875613
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
